CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
-9.14%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.68B
AUM Growth
+$1.68B
(-32%)
Cap. Flow
-$192M
Cap. Flow
% of AUM
-11.44%
Top 10 Holdings %
Top 10 Hldgs %
50.05%
Holding
96
New
8
Increased
9
Reduced
34
Closed
18
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
$31.9M |
| 2 |
Ventyx Biosciences
VTYX
|
$15.1M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$14.7M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$14.6M |
| 5 |
Adicet Bio
ACET
|
$13.1M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$29M |
| 2 |
AGEN
Agenus
AGEN
|
$25.2M |
| 3 |
Revolution Medicines
RVMD
|
$17.9M |
| 4 |
Ascendis Pharma
ASND
|
$16.1M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$15.4M |
Sector Composition
| 1 | Healthcare | 99.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rocket Pharmaceuticals
RCKT
$358M
| $19M | 1.13% |
868,550
-100,000
| -10% | -$2.18M |
|
27
Tourmaline Bio
TRML
$645M
| $18.1M | 1.08% |
1,182,545
-33,302
| -3% | -$509K |
|
|
AXNX
28
DELISTED
Axonics, Inc. Common Stock
AXNX
| $18M | 1.07% |
322,240
| – | – |
|
29
ALX Oncology
ALXO
$54.6M
| $16.4M | 0.97% |
762,079
-250,000
| -25% | -$5.37M |
|
|
30
Ventyx Biosciences
VTYX
$184M
| $15.1M | 0.9% |
+785,303
| New | +$15.1M |
|
|
31
Atea Pharmaceuticals
AVIR
$275M
| $15M | 0.89% |
1,679,442
-3,249,314
| -66% | -$29M |
|
32
Praxis Precision Medicines
PRAX
$980M
| $14.8M | 0.88% |
752,406
-271,755
| -27% | -$5.35M |
|
|
IGMS
33
DELISTED
IGM Biosciences
IGMS
| $14.7M | 0.87% |
500,000
+150,000
| +43% | +$4.4M |
|
|
CCXI
34
DELISTED
ChemoCentryx, Inc.
CCXI
| $14.6M | 0.87% |
+400,000
| New | +$14.6M |
|
35
GH Research
GHRS
$870M
| $14.2M | 0.84% |
608,123
| – | – |
|
|
36
Adicet Bio
ACET
$60.8M
| $13.1M | 0.78% |
+750,000
| New | +$13.1M |
|
37
Aclaris Therapeutics
ACRS
$223M
| $13.1M | 0.78% |
900,000
-600,000
| -40% | -$8.72M |
|
|
ELEV
38
DELISTED
Elevation Oncology
ELEV
| $11.9M | 0.71% |
1,983,165
| – | – |
|
39
Tyra Biosciences
TYRA
$657M
| $11.6M | 0.69% |
839,932
-230,000
| -21% | -$3.18M |
|
|
LBPH
40
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $11.1M | 0.66% |
2,273,221
| – | – |
|
|
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11M | 0.65% |
75,000
-45,000
| -38% | -$6.6M |
|
|
VECT
42
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $10.9M | 0.65% |
2,216,763
-9,365
| -0.4% | -$46K |
|
43
Pharvaris
PHVS
$1.41B
| $9.93M | 0.59% |
689,731
| – | – |
|
44
Zymeworks
ZYME
$1.07B
| $9.83M | 0.58% |
600,000
-350,000
| -37% | -$5.74M |
|
|
ICVX
45
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $9.76M | 0.58% |
426,393
| – | – |
|
46
Keros Therapeutics
KROS
$640M
| $8.78M | 0.52% |
+150,000
| New | +$8.78M |
|
47
Akero Therapeutics
AKRO
$3.65B
| $8.54M | 0.51% |
403,787
-196,213
| -33% | -$4.15M |
|
48
Pyxis Oncology
PYXS
$91.2M
| $7.12M | 0.42% |
+668,854
| New | +$7.12M |
|
|
ITOS
49
DELISTED
iTeos Therapeutics
ITOS
| $6.98M | 0.42% |
150,000
-138,330
| -48% | -$6.44M |
|
|
50
Ascendis Pharma
ASND
$12.1B
| $6.73M | 0.4% |
50,000
-120,000
| -71% | -$16.1M |
|